Compound class:
Synthetic organic
Comment: The peptide vinyl sulfone, WLL-vs, is a highly selective covalent inhibitor of the P. falciparum proteasome [1].
The Malaria tab on this ligand page provides additional curator comments of relevance to the Guide to MALARIA PHARMACOLOGY. ![]() Ligand Activity Visualisation ChartsThese are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts. ✖ |
|
Guide to Malaria Pharmacology Comments |
Second-generation vinyl sulfone inhibitors, with improved selectivity, have been identified following medicinal chemistry efforts to optimize WLL-vs [3]. However, concerns about long-term host toxicity remain due to micromolar potency against the human proteosome, an issue that must be addressed to advance this class of inhibitor. Potential Target/Mechanism Of Action: WLL-vs is an inhibitor of the β2 and β5 subunits of the of P. falciparum proteasome. |